Tissue Regenix Group plc
("Tissue Regenix" or "the Group")
World's first OrthoPure™ XT (dCELL® Tendon) implants successfully undertaken at Barcelona Hospital
York 4th December 2015, Tissue Regenix Ltd, (AIM:TRX) "Tissue Regenix" or "The Group" the regenerative medical device company, is pleased to announce that two patients have received the first OrthoPure™ XT decellularised tendons using Tissue Regenix patented dCELL® technology. This has been done as part of a clinical safety study by Tissue Regenix which is being conducted to secure a CE mark to enable launch of the OrthoPure™ XT in the EU in 2017.
Orthopaedic & Trauma Surgeon, Dr.
